HomeTECH • NASDAQ
Follow
BIO-TECHNE Corp
Previous close
$65.52
Day range
$63.65 - $65.29
Year range
$51.79 - $89.91
Market cap
10.09B USD
Avg Volume
1.05M
P/E ratio
46.32
Dividend yield
0.50%
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 272.60M | 0.37% |
Operating expense | 127.81M | 19.27% |
Net income | 27.46M | -45.08% |
Net profit margin | 10.08 | -45.25% |
Earnings per share | 0.40 | -14.89% |
EBITDA | 77.94M | -24.33% |
Effective tax rate | 17.74% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 135.65M | -31.06% |
Total assets | 2.73B | 15.54% |
Total liabilities | 767.19M | 43.05% |
Total equity | 1.96B | — |
Shares outstanding | 157.19M | — |
Price to book | 5.24 | — |
Return on assets | 4.57% | — |
Return on capital | 4.95% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 27.46M | -45.08% |
Cash from operations | 83.12M | 29.09% |
Cash from investing | -23.67M | -21,616.51% |
Cash from financing | -81.40M | -12.75% |
Net change in cash | -18.53M | -3,122.78% |
Free cash flow | 37.00M | -7.14% |
About
Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
Founded
1976
Headquarters
Website
Employees
3,050
